New Key Statistics Module, Z-Score and F-Score
NEOE:LLY Key Ratios
Market Cap C$ M | 1,089,492.10 |
Enterprise Value C$ M | 1,121,837.54 |
P/E(ttm) | 125.42 |
PE Ratio without NRI | 85.62 |
Forward PE Ratio | 60.99 |
Price/Book | 62.11 |
Price/Sales | 21.03 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 48,312.00 |
EPS (TTM) C$ | 8.96 |
Beneish M-Score | -1.87 |
10-y EBITDA Growth Rate % | 8.80 |
5-y EBITDA Growth Rate % | 10.70 |
y-y EBITDA Growth Rate % | 20.00 |
EV-to-EBIT | 100.86 |
EV-to-EBITDA | 84.57 |
PEG | 8.00 |
Shares Outstanding M | 950.41 |
Net Margin (%) | 17.08 |
Operating Margin % | 33.51 |
Pre-tax Margin (%) | 21.04 |
Quick Ratio | 1.03 |
Current Ratio | 1.35 |
ROA % (ttm) | 10.45 |
ROE % (ttm) | 53.79 |
ROIC % (ttm) | 22.81 |
Dividend Yield % | 0.31 |
Altman Z-Score | 10.73 |
NEOE:LLY Number of Guru Trades
NEOE:LLY Volume of Guru Trades
Gurus Latest Trades with NEOE:LLY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NEOE:LLY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Eli Lilly and Co Insider Transactions
No Available Data